Award
National Heart, Lung, and Blood Institute 5U24HL143217-07
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
Recipient
National Heart Lung and Blood Institute (NHLBI)
Award Amount
$702,819.00
Ceiling
$702,819.00
Awarded
April 19, 2025
Identifier
5U24HL143217-07
Award for a clinical trial studying sickle cell disease and cardiovascular risk, funded by the National Heart Lung and Blood Institute.
Description
This is a clinical trial focusing on sickle cell disease and cardiovascular risk, involving blood transfusions and echocardiography assessments. The project is funded by NIH/NHLBI and involves multiple clinical sites.